HCPLive Network

Increase in Proportion of Livers Not Used for Transplantation

 
TUESDAY, Jan. 22 (HealthDay News) -- The proportion of livers not used for transplantation is increasing, with the primary causes being donation after cardiac death (DCD), older donor age, greater body mass index (BMI), and increasing diabetes prevalence, according to research published in the January issue of Liver Transplantation.

Eric S. Orman, M.D., of the University of North Carolina at Chapel Hill, and colleagues used data from the United Network for Organ Sharing database for 107,259 organ donors to examine trends in donor liver utilization and the association between donor characteristics and liver nonuse between 2004 and 2010.

The researchers found that the number of unused livers decreased from 66 percent of donors in 1988 to 15 percent in 2004, and then increased to 21 percent in 2010. Over time, donor age, BMI, and the prevalence of diabetes and DCD all increased, and these factors correlated with liver nonuse. The odds ratio for nonuse was highest for DCD and increased from 5.53 in 2004 to 21.31 in 2011. Overall, in 2010, DCD accounted for 28 percent of all liver nonuse, up from 9 percent in 2004.

"A better understanding of the reasons for the increasing proportion of DCD in particular is critical to understanding this declining utilization," the authors write. "These trends, along with stagnant donation rates, suggest significant declines in liver transplant availability in the coming years."
 

Abstract
Full Text


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Preliminary results from the M12-999 study show that treatment with ABT-450/ritonavir/ombitasvir plus dasabuvir and ribavirin is well tolerated and associated with high rates of sustained virologic response in adult liver transplant recipients with recurrent HCV genotype 1 infection.
Study results show hepatic decompensation is more common in people who have both HIV and hepatitis C virus (HCV) compared to those infected only with HCV, an indication that early HCV treatment among coinfected patients is needed.
Study of farnesoid-x receptor agonist demonstrates protective effects on bacterial translocation from the small intestine in rat model of cholestatic liver disease.
Autoimmune hepatitis often responds well to steroid therapy but identifying the disease and the best approach to management is filled with complexities.
There are several known risk factors and “red flags” that should prompt clinicians to suspect nonalcoholic steatohepatitis or nonalcoholic fatty liver disease and conduct appropriate testing.
Men and women with fatty liver are more likely to have metabolic syndrome with type 2 diabetes, and women with fatty liver are more likely to have metabolic syndrome with subclinical atherosclerosis, according to research published online Dec. 18 in Diabetes Care.
Acetaminophen toxicity is the second most common cause of liver failure requiring transplantation in the US.
More Reading